Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tracon Pharmaceuticals Inc (NQ: TCON ) 1.430 UNCHANGED Last Price Updated: 4:00 PM EDT, Jun 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Tracon Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 8 9 Next > 12 Health Care Stocks Moving In Monday's Intraday Session December 27, 2021 Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 47.87% to $8.02 during Monday's regular session. The current volume of 63.6 million shares is 153229.83%... Via Benzinga 34 Stocks Moving In Monday's Mid-Day Session December 27, 2021 Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 23, 2021 Gainers Pasithea Therapeutics (NASDAQ: Via Benzinga Capital Efficient: Clinical Stage NASDAQ Company - Novel Targeted Cancer Therapeutics Company: TRACON Pharmaceuticals (NASDAQ: TCON) August 16, 2021 Via Viz Release 54 Biggest Movers From Thursday December 27, 2021 Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session December 20, 2021 Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD Via Benzinga 5 Penny Stocks Insiders Are Buying December 08, 2021 When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 02, 2021 Gainers Omeros (NASDAQ:OMER) stock increased by 15.68% to $7.89 during Thursday's pre-market session. The market value of their outstanding shares is at $493.4 million... Via Benzinga Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xenco In $480 Million Deal November 27, 2021 In a $480 million deal, Zenas acquired global rights to a bifunctional antibody from Xencor that targets CD19. Instead of an upfront payment, Zenas will issue a warrant granting Xencor the right to... Via Talk Markets 5 Stocks Insiders Are Still Buying (Even As Others Cash Out) November 12, 2021 Insider sales are generally a sign the market is about to drop, but not everyone's selling. Here are five companies with insider buying. Via InvestorPlace Week In Review: Hansoh Signs $456 Million Deal For siRNA Products October 16, 2021 Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to... Via Talk Markets Earnings Scheduled For November 3, 2021 November 03, 2021 Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... Via Benzinga TRACON Pharma, Eucure Join Forces To Develop CTLA-4 Antibody For Oncology Indications October 11, 2021 TRACON Pharmaceuticals Inc (NASDAQ: TCON) entered into a collaborative partnership agreement with Eucure Biopharma, a subsidiary of Biocytogen Pharmaceuticals (... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session October 11, 2021 Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at... Via Benzinga TRACON Pharmaceuticals on the Fast Track for Sarcoma Injection Treatments September 07, 2021 Sarcoma is not one of the many cancers that reaches top billing in the discussion of cancer research. The cancer starts in tissues like bone, muscle or soft tissue and... Via Benzinga Clinical Stage Trials, Novel Targeted Cancer Therapeutics and $25.6 Million in the Bank to Persevere this NASDAQ through 2023: TRACON Pharmaceuticals (NASDAQ: TCON) August 31, 2021 Via Get News 25.6 Million in cash will Bankroll this NASDAQ until 2023; Capitol Efficient Clinical Stage, Novel Targeted Cancer Therapeutics: TRACON Pharmaceuticals (NASDAQ: TCON) August 31, 2021 Via Viz Release 25.6 Million in cash will Bankroll this NASDAQ until 2023; Capitol Efficient Clinical Stage, Novel Targeted Cancer Therapeutics: TRACON Pharmaceuticals (NASDAQ: TCON) August 31, 2021 Via Get News Capital Efficient: Clinical Stage NASDAQ Company – Novel Targeted Cancer Therapeutics Company: TRACON Pharmaceuticals (NASDAQ: TCON) August 16, 2021 Via Get News Earnings Scheduled For August 11, 2021 August 11, 2021 Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is... Via Benzinga The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma August 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety 3 Penny Stocks Insiders Are Buying July 28, 2021 When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session July 26, 2021 Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG... Via Benzinga 61 Biggest Movers From Yesterday July 23, 2021 Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy... Via Benzinga Mid-Afternoon Market Update: Dow Rises Over 50 Points; ImmunoPrecise Antibodies Shares Spike Higher July 22, 2021 Toward the end of trading Thursday, the Dow traded up 0.16% to 34,853.89 while the NASDAQ rose 0.38% to 14,687.85. The S&P also rose, gaining 0.20% to 4,367.55. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 38 Stocks Moving In Thursday's Mid-Day Session July 22, 2021 Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating... Via Benzinga Mid-Day Market Update: Crude Oil Up 1.5%; Seres Therapeutics Shares Plunge July 22, 2021 Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70. The U.S. has... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Thursday's Intraday Session July 22, 2021 Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 53.01% to $15.47 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume... Via Benzinga Mid-Morning Market Update: Markets Mostly Lower; AT&T Beats Q2 Estimates July 22, 2021 Following the market opening Thursday, the Dow traded down 0.24% to 34,715.42 while the NASDAQ rose 0.13% to 14,651.19. The S&P also fell, dropping 0.08% to 4,355.29. The U.S... Via Benzinga Topics Stocks Exposures US Equities The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO July 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
